Arete Wealth Advisors, LLC - ONCOCYTE CORP ownership

Back to all holdings Add to watchlist

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 58 filers reported holding ONCOCYTE CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Arete Wealth Advisors, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2020$17,000
-29.2%
12,5000.0%0.00%
-25.0%
Q2 2020$24,000
-22.6%
12,5000.0%0.00%
-33.3%
Q1 2020$31,000
+10.7%
12,5000.0%0.01%
+20.0%
Q4 2019$28,000
+7.7%
12,5000.0%0.01%0.0%
Q3 2019$26,000–12,500–0.01%–
 Download
Other shareholders
ONCOCYTE CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders